Revenue
393 million USD
2025 Q1 · USD
Exact inputs and evidence
- Revenue: 392833000 USD Source
Fundies. English
Endo, Inc.
EDGARAnnual consolidated revenue for 2024: about USD 1.178B, using the latest reported figures.
Latest quarter
Net margin
-32.74%
2025 Q1 · %
Operating cash flow
1.13 million USD
2025 Q1 · USD
Exact inputs and evidence
- Operating Cash Flow: 1128000 USD Source
Free cash flow
-12.5 million USD
2025 Q1 · USD
- Cash and cash equivalents
- 370 million USD Source
Exact value
369683000 USD
- Long-term debt including current maturities
- 2.44 billion USD
Exact inputs and evidence
2435747000 USD
- Long-term debt including current maturities: 2435747000 USD Source
- Shares outstanding
- 76.2 million shares Source
Exact value
76211329 shares
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Net income
-859 million USD
2024-04-01 – 2025-03-31
Exact inputs and evidence
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2025-05-12.
Financial data available through: 2024-12-31.
Coverage by financial measure
- Revenue: 1 of 11 periods available· newest 2024-12-31
- operating income: No compatible figures in this window
- Net income: 1 of 11 periods available· newest 2024-12-31
- Operating cash flow: 1 of 11 periods available· newest 2024-12-31
- Capital expenditure: 1 of 11 periods available· newest 2024-12-31
- Total assets: 1 of 11 periods available· newest 2024-12-31
- liabilities: No compatible figures in this window
- Current assets: 1 of 11 periods available· newest 2024-12-31
- Current liabilities: 1 of 11 periods available· newest 2024-12-31
- Cash and cash equivalents: 1 of 11 periods available· newest 2024-12-31
- Long-term debt including current maturities: 1 of 11 periods available· newest 2024-12-31
- Shares outstanding: 1 of 11 periods available· newest 2024-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
No unambiguous prior-year comparison is available for the latest reporting period.
Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2024 2024-01-01 – 2024-12-31
- Revenue USD 1.18 billion 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income −USD 730.86 million −62% of revenue
Cash
- Operating cash flow USD 113.42 million 9.6% of revenue
- Capital expenditure USD 36.99 million 3.1% of revenue
- Free cash flow Derived USD 76.43 million 6.5% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2024 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2024 2024-01-01 – 2024-12-31 | 1178166000 | Unavailable | Unavailable | Unavailable | -730864000 | 76426000 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 1.2B 2024
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Revenue | 1178166000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Net margin -62% 2024
Free cash flow margin 6.5% 2024
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024-12-31 | Operating margin | Not reported |
|
| 2024 | Net margin | -62% |
|
| 2024 | Free cash flow margin | 6.5% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 113.4M 2024
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Operating cash flow | 113419000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD 76.4M 2024
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Free cash flow | 76426000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024-12-31 | Liabilities / assets | Not reported |
|
Current assets to current liabilities
Current assets divided by current liabilities.
2.87× 2024
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Current assets / current liabilities | 2.87× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2024 2024-01-01 – 2024-12-31 | −USD 730.86 million Exact valueExact value: -730864000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 113.42 million Exact valueExact value: 113419000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 36.99 million Exact valueExact value: 36993000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 76.43 million Calculation and evidence113419000 − 36993000 USD Exact free cash flow: 76426000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
5 filings · 820 latest values · 819 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002008861, 2008861, edgar:2008861
Also known as Endo LP, Endo, Inc.